2025年6月7日，第62届欧洲肾脏协会年会（ERA）在奥地利维也纳圆满落幕。作为全球肾脏病学领域顶尖的学术盛会，本次会议汇聚了众多国际知名专家，并展示了多项前沿突破与创新实践成果。我国肾脏病学者共有90余篇研究摘要入选本届大会，研究内容涵盖肾脏病学 ...

With increasing understanding of the underlying pathophysiological processes implicated in diabetic nephropathy, new specific renoprotective treatment strategies are anticipated to become ...

The global diabetic nephropathy market revenue was around US$ 2.0 billion in 2022 and is estimated to reach US$ 3.3 billion by 2031, growing at a compound annual growth rate (CAGR) of 6% during the ...

Diabetic nephropathy has severe individual and societal consequences, owing to its high morbidity, mortality and health-care costs Despite the availability of anti-glycaemic, renoprotective and ...

The basis for the prevention of diabetic nephropathy is the treatment of its known risk factors: hypertension, hyperglycemia, smoking, and dyslipidemia. These are also risk factors for ...

The diabetic nephropathy market is driven by the growing burden of diabetes and the increasing demand for effective treatments for kidney disease. Advances in therapeutics, including new drug classes ...

Renal biopsy is only recommended in special situations. The diagnosis of diabetic nephropathy is easily established in long-term type 1 diabetic patients (>10 years diabetes duration), especially ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when ...

However, diabetic nephropathy doesn’t occur right when you first get diabetes. It may take around 10 years to develop, though ...

Lowering blood pressure and maintaining blood sugar control are absolutely necessary to slow the progression of diabetic nephropathy. There are medications available which have been found to slow ...

Research has shown that angiotensin converting enzyme (ACE) inhibitors help manage diabetic nephropathy-related issues. They can also slow the progression of diabetic nephropathy in some people.

Diabetic nephropathy develops slowly over several years. There may be no symptoms in its early stages. Treatment may prevent it from progressing and leading to serious conditions, like end stage ...